OSMI-4 (C09-0998-154)

Aladdin

Catalog No.: C09-0998-154
Manufacturer No.: O422714-1ml
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Price: $311.01

List Price: $345.57

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

InformationOSMI-4 OSMI-4 is an inhibitor of O-GlcNAc transferase (OGT) with EC50 of 3 μM in cells.TargetsOGT (Cell-free assay) 3 μM(EC50)In vitroOSMI-4 reduces O-GlcNAc levels almost completely by 5 μM. A decrease in HCF-1 cleavage products and the appearance of uncleaved HCF-1 is observed in cells treated with OSMI-4. OSMI-4 is a kind of structure-based evolution of small molecule OGT inhibitors with low nanomolar binding affinities. OSMI-4 exhibits a ~3 μM EC50 in cells, making it especially attractive for probing OGT’s complex biology.Cell Research(from reference)Cell lines：HEK293T cells Concentrations：5 μM, 10 μM, 20 μM Incubation Time：2 h, 8 h, 16 h, 24 h. Specification: 10mM in DMSO Molecular Formula: C27H26ClN3O7S2 Molecular Weight: 604.09 PubChem CID: 137319721

UPC:: 12352005
Condition:: New
Availability:: 2 weeks
Weight:: 0.85 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: O422714-1ml
CAS:: 2260791-14-6
Product Size:: 1ml

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."